How can scientists leverage AI and machine learning to more effectively research, develop, and deliver new drugs? This week, Reid and Aria talk drug development with renowned computer scientist and executive Dr. Daphne Koller, whose company, insitro, uses machine learning to improve the quality and speed of drug discovery. She addresses several ways AI and ML are already being used to redefine diseases and create better therapeutic interventions. Plus, she shares her experience transitioning from academia to industry. Read the transcript of this episode here: https://www.possible.fm/podcasts/dkollerFor more info on the podcast and transcripts of all the episodes, visit https://www.possible.fm/podcast/ Topics:00:01: Cold open00:43: Hellos and intros3:20: Early involvement in AI 5:00: Overview of drug discovery and its evolution over the last five years 7:50: AI and machine learning impact on biology and drug development 9:09: Pi aside defining AlphaFold 11:37: Areas of acceleration and opportunity in AI and drug discovery 17:21: Synthetic data 21:21: AI implications on therapeutic hypotheses 23:54: Personalized vs. precision medicine 27:04: Closing the data feedback loop 30:31: Exciting announcements 34:24: Privacy and data36:41: GPT-4 story 38:48: Stuart Russell’s comments on the applications of Koller’s thesis 43:36: AI as a moving target47:24: How can academia and industry positively impact society and humanity51:58: insitro’s culture 54:18: - Rapid-fire questionsSelect mentions: Not the End of the World: How We Can Be the First Generation to build a Sustainable Planet by Hannah RitchieStuart RussellPossible is an award-winning podcast that sketches out the brightest version of the future—and what it will take to get there. Most of all, it asks: what if, in the future, everything breaks humanity's way? Tune in for grounded and speculative takes on how technology—and, in particular, AI—is inspiring change and transforming the future. Hosted by Reid Hoffman and Aria Finger, each episode features an interview with an ambitious builder or deep thinker on a topic, from art to geopolitics and from healthcare to education. These conversations also showcase another kind of guest: AI. Whether it's Inflection’s Pi, OpenAI’s ChatGPT or other AI tools, each episode will use AI to enhance and advance our discussion about what humanity could possibly get right if we leverage technology—and our collective effort—effectively.